Pfizer Amgen: That Pfizer’s Seagen Bet Could Lead
Pfizer’s Seagen integration is starting to pay off, signaling a shift in oncology bets as Amgen pursues a rebuild thr...
This guide covers withdrawal-friendly total market ETFs and how to structure distributions to maximize cash flow while controlling taxes in retirement.
28,154 articlesPfizer’s Seagen integration is starting to pay off, signaling a shift in oncology bets as Amgen pursues a rebuild thr...
Christopher Nolan’s The Odyssey opened to $264 million worldwide, surpassing a $250 million budget and signaling how ...
Austin Niemiec returns to lead Rocket Pro as executives depart, signaling a strengthened wholesale channel amid a vol...
A Life360 board director recently sold several thousand shares after exercising options, timing that coincides with a...
Palantir stock investors just got new cues from the Street. This guide explains what the headlines might mean, how to...
Can bloom energy stock going to $200 actually happen? This guide breaks down the catalysts, risks, and practical stra...
A seasoned crypto insider takes a patient stance in the current climate. Learn why waiting can be a smarter move than...
Carvana’s eye-popping ascent sparked debates about online car shopping and disruption. As Amazon weighs in on automot...
Nebius Group keeps powering higher as AI-driven data centers fuel growth. This article breaks down what’s behind the ...
As bond yields wobble, energy stocks secretly better provide income with inflation protection and strong cash flow. E...
As Baozun charts its path in 2026, investors want clarity on revenue growth, margins, and strategic bets. This articl...
Oracle's backlog surge and accelerating AI infrastructure growth are fueling a heated debate on whether the stock is ...